Literature DB >> 16190768

High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor.

Chen Li1, Wei Xu, Subramanian K Vadivel, Pusheng Fan, Alexandros Makriyannis.   

Abstract

We have designed and synthesized the first two high affinity covalent anandamide probes for the CB1 receptor by introducing either an electrophilic isothiocyanato or a photoactivatable azido group at the terminal carbon of the arachidonic acid moiety. The headgroup of these anandamide analogues was optimized by using a cyclopropylamide substituent to impart optimal CB1 affinity. Both 20-isothiocyanato-eicosa-5,8,11,14-tetraenoic acid cyclopropylamide (1, AM3677) and 20-azido-eicosa-5,8,11,14-tetraenoic acid cyclopropylamide (2, AM3661) exhibited high selectivities for the CB1 receptor with K(i) values of 1.3 and 0.9 nM, respectively. Using suitable experimental conditions, both ligands were shown to covalently label the CB1 receptor with high efficiency. These two covalent probes for the endocannabinoid CB1 binding site open the door for exploring the ligand binding motifs involved in the activation of the CB1 receptor by its endogenous ligand, anandamide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190768     DOI: 10.1021/jm050272i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids.

Authors:  Demetris P Papahatjis; Victoria R Nahmias; Spyros P Nikas; Marion Schimpgen; Alexandros Makriyannis
Journal:  Chemistry       Date:  2010-04-06       Impact factor: 5.236

2.  Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.

Authors:  David R Janero; Suma Yaddanapudi; Nikolai Zvonok; Kumar V Subramanian; Vidyanand G Shukla; Edward Stahl; Lei Zhou; Dow Hurst; James Wager-Miller; Laura M Bohn; Patricia H Reggio; Ken Mackie; Alexandros Makriyannis
Journal:  ACS Chem Neurosci       Date:  2015-05-29       Impact factor: 4.418

3.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

4.  Application of Chemoenzymatic Hydrolysis in the Synthesis of 2-Monoacylglycerols.

Authors:  Kyle M Whitten; Alexandros Makriyannis; Subramanian K Vadivel
Journal:  Tetrahedron       Date:  2012-05-05       Impact factor: 2.457

5.  Crystal Structure of the Human Cannabinoid Receptor CB1.

Authors:  Tian Hua; Kiran Vemuri; Mengchen Pu; Lu Qu; Gye Won Han; Yiran Wu; Suwen Zhao; Wenqing Shui; Shanshan Li; Anisha Korde; Robert B Laprairie; Edward L Stahl; Jo-Hao Ho; Nikolai Zvonok; Han Zhou; Irina Kufareva; Beili Wu; Qiang Zhao; Michael A Hanson; Laura M Bohn; Alexandros Makriyannis; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

6.  3'-functionalized adamantyl cannabinoid receptor probes.

Authors:  Go Ogawa; Marcus A Tius; Han Zhou; Spyros P Nikas; Aneetha Halikhedkar; Srikrishnan Mallipeddi; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2015-03-20       Impact factor: 7.446

7.  Conformationally constrained analogues of 2-arachidonoylglycerol.

Authors:  Subramanian K Vadivel; Sundararaman Vardarajan; Richard I Duclos; JodiAnne T Wood; Jianxin Guo; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2007-08-21       Impact factor: 2.823

8.  Gas chromatography-mass spectrometry of JWH-018 metabolites in urine samples with direct comparison to analytical standards.

Authors:  Beth Emerson; Bill Durham; Jennifer Gidden; Jackson O Lay
Journal:  Forensic Sci Int       Date:  2013-04-09       Impact factor: 2.395

9.  Enzymatic synthesis of N-Acylethanolamines: Direct method for the aminolysis of esters.

Authors:  Kyle M Whitten; Alexandros Makriyannis; Subramanian K Vadivel
Journal:  Tetrahedron Lett       Date:  2012-08-18       Impact factor: 2.415

10.  Development of novel tail-modified anandamide analogs.

Authors:  Fenmei Yao; Chen Li; Subramanian K Vadivel; Anna L Bowman; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2008-07-31       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.